Investments
1Latest Sijia Jianxin Fund News
Nov 9, 2017
Send to AnchorDx, a China-based company that develops new clinical diagnosis products based on next-generation sequencing (NGS) technology, has raised $28 million in a Series B round led by 6 Dimensions Capital and Sijia Jianxin Fund. New investors Arch Venture Partners, contract research outsourcing provider WuXi AppTec and medical testing services provider Guangzhou KingMed also participated, as did existing backer Marathon Venture... To continue reading...
Sijia Jianxin Fund Investments
1 Investments
Sijia Jianxin Fund has made 1 investments. Their latest investment was in AnchorDx as part of their Series B on November 11, 2017.
Sijia Jianxin Fund Investments Activity
Date | Round | Company | Amount | New? | Co-Investors | Sources |
|---|---|---|---|---|---|---|
11/7/2017 | Series B | AnchorDx | $28M | Yes | 10 |
Date | 11/7/2017 |
|---|---|
Round | Series B |
Company | AnchorDx |
Amount | $28M |
New? | Yes |
Co-Investors | |
Sources | 10 |
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.